Prophylactic lidocaine in acute myocardial infarction: Resurface or reburial?

American Journal of Cardiology

Volumn 94, Issue 5, 2004, Pages 606-608

  Yadav, Anil V ^a,b   Zipes, Douglas P ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Veterans Administration   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; LIDOCAINE; MEXILETINE;

CARDIOGENIC SHOCK; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY CARE UNIT; DRUG DELIVERY SYSTEM; DRUG EFFECT; EDITORIAL; HEART INFARCTION; HUMAN; LUNG EDEMA; META ANALYSIS; PATIENT CARE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZATION; ST SEGMENT ELEVATION; UNITED STATES;

EID: 4444325442     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.05.024     Document Type: Note

References (23)

1. McCaig LF, Burt CW. National Hospital Ambulatory Medical Care Survey: 2002 Emergency Department Summary. Atlanta, GA: Centers for Disease Control and Prevention, Division of Health Care Statistics; 2002.
2. National Heart and Lung Blood Institute Task Force report on research in the prevention of cardiovascular disease. Bethesda, MD: National Institutes of Health; 2001.
3. T.J. Ryan, J.L. Anderson, E.M. Antman, B.A. Braniff, N.H. Brooks, R.M. Califf, L.D. Hillis, L.F. Hiratzka, E. Rapaport, B.J Riegel ACC/AHA guidelines for the management of patients with acute myocardial infarction J Am Coll Cardiol 28 1996 1328 1428
4. R. Gianelly, J.O. von der Groeben, A.P. Spivack, D.C. Harrison Effect of lidocaine on ventricular arrhythmias in patients with coronary heart disease N Engl J Med 277 1967 1215 1219
5. J. Koch-Weser, S.W. Klein, L.L. Foo-Canto, J.A. Kastor, R.W. DeSanctis Antiarrhythmic prophylaxis with procainimide in acute myocardial infarction N Engl J Med 281 1969 1253 1260
6. A. Pitt, H. Lipp, T.S. Anderson Lignocaine given prophylactically to patients with acute myocardial infarction Lancet 1 1971 612 616
7. P.A. Valentine, J.L. Frew, M.L. Mashford, J.G. Sloman Lidociane in the prevention of sudden death in the pre-hospital phase of acute infarction N Engl J Med 291 1974 1327 1331
8. K.I. Lie, H.J. Wellens, F.J. van Capelle, D. Durrer Lidocaine in the prevention of primary ventricular fibrillation; a double blind, randomized study of 212 consecutive patients N Engl J Med 291 1974 1324 1326
9. K.I. Lie, K.L. Liem, W.J. Louridtz, M.J. Janse, A.F. Willebrands, D. Durrer Efficacy of lidocaine in preventing primary ventricular fibrillation within 1 hour after a 300mg intramuscular injection Am J Cardiol 42 1978 486 488
10. R.A. DeSilva, B. Lown, C.H. Hennekens, W. Casscells Lignocaine prophylaxis in acute myocardial infarction an evaluation of randomized trials Lancet 2 1981 855 858
11. S. MacMahon, R. Collins, R. Peto, R.W. Koster, S. Yusuf Effects of prophylactic lidocaine in suspected acute myocardial infarction an overview of results from the randomized, controlled trials JAMA 260 1988 1910 1916
12. L.K. Hine, N. Laird, P. Hewitt, T.C. Chalmers Meta-analytic evidence against the prophylactic use of lidocaine in acute myocardial infarction Arch Intern Med 149 1989 2694 2698
13. K.K. Teo, S. Yusuf, C.D. Furberg Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction an overview of results from randomized controlled trials JAMA 270 1993 1589 1595
14. R.W. Koster, A.J. Dunning Intramuscular lidocaine for the prevention of lethal arrhythmias in the prehospitalization phase of acute myocardial infarction N Engl J Med 313 1985 1105 1110
15. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators Preliminary report effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction N Engl J Med 321 1989 406 410
16. IMPACT Research Group International Mexiletine, Placebo Antiarrhythmic Coronary Trial, I. Report on arrhythmia and other findings J Am Coll Cardiol 4 1984 1148 1163
17. A.L. Waldo, A.J. Camm, H. deRuyter, P.L. Friedman, D.J. MacNeil, J.F. Pauls, B. Pitt, C.M. Pratt, P.J. Schwartz, E.P. Veltri Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction Lancet 348 1996 7 12
18. Wyman MG, Wyman MR, Cannom DS, Criley JM. Am J Cardiol 2004; in press.
19. E.A. Antman, J.A. Berlin Declining incidence of ventricular fibrillation in myocardial infarction implications for the prophylactic use of lidocaine Circulation 86 1992 764 773
20. S. Behar, U. Goldbourt, H. Reicher-Reiss, E. Kaplinsky Prognosis of acute myocardial infarction complicated by primary ventricular fibrillation principal investigators of the SPRINT Study Am J Cardiol 66 1990 1208 1211
21. Z.P. Sadowski, J.H. Alexander, B. Skrabucha, A. Dyduszynski, J. Kuch, E. Nartowicz, G. Swiatecka, D.F. Kong, C.B. Granger Multicenter randomized trial and a systemic overview of lidocaine in acute myocardial infarction Am Heart J 137 1999 792 798
22. J.H. Alexander, C.B. Granger, Z. Sadowski, P.E. Aylward, H.D. White, T.D. Thompson, R.M. Califf, E.J. Topol Prophylactic lidocaine use in acute myocardial infarction. Incidence and outcomes from two international trials Am Heart J 137 1999 799 805
23. S.M. Al-Khatib, A.L. Stebbins, R.M. Califf, K.L. Lee, C.B. Granger, H.D. White, P.W. Armstrong, E.J. Topol, E.M. Ohman Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction results from the GUSTO III trial Am Heart J 145 2003 515 521